SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
30 hedge funds and large institutions have $6.45M invested in Sophiris Bio, Inc. in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 6 closing their positions.
Holders
30
Holders Change
-4
Holders Change %
-11.76%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
11
Reduced
7
Closed
6
Calls
$500K
Puts
$356K
Net Calls
+$144K
Net Calls Change
+$198K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$3.82M |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$595K |
| 3 |
3
JPMorgan Chase & Co
New York
|
$247K |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$226K |
| 5 |
BO
5
BRR OpCo
Columbus,
Ohio
|
$112K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$0 |
| 2 |
2
Goldman Sachs
New York
|
$0 |
| 3 |
BAM
3
Belpointe Asset Management
Reno,
Nevada
|
$0 |
| 4 |
VF
4
Virtu Financial
New York
|
$0 |
| 5 |
5
Bank of New York Mellon
New York
|
$68K |
